Trial intelligence / Profile preview

Intralesional tuberculin vs cryotherapy for treatment-resistant warts

IRCT201407089844N3Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Oct 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of tuberculin purified protein derivative in verruca (2 arms), sponsored by Tabriz University of Medical Sciences. Started Oct 2013; status: completed.

02

Drugs

tuberculin purified protein derivative
03

Conditions

verruca

Beyond the preview

Go deeper on IRCT201407089844N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201407089844N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call